XML 48 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
6 Months Ended
Oct. 01, 2011
Oct. 02, 2010
Cash Flows from Operating Activities:  
Net income$ 30,828$ 39,257
Non cash items:  
Depreciation and amortization24,61924,690
Stock compensation expense4,7014,089
Loss on sales of property, plant and equipment278316
Unrealized loss from hedging activities1,0801,133
Contingent consideration income(1,580)(1,894)
Reversal of interest expense on contingent consideration(574)(493)
Change in operating assets and liabilities:  
Increase in accounts receivable, net(1,332)(837)
Increase in inventories(15,390)(3,900)
Decrease in prepaid income taxes12,2836,849
Increase in other assets and other long-term liabilities(1,267)(3,727)
Tax benefit on exercise of stock options952946
Decrease in accounts payable and accrued expenses(2,059)(22,143)
Net cash provided by operating activities52,53944,286
Cash Flows from Investing Activities:  
Capital expenditures on property, plant and equipment(23,843)(24,088)
Proceeds from sale of property, plant and equipment130262
Net cash used in investing activities(23,713)(23,826)
Cash Flows from Financing Activities:  
Payments on long-term real estate mortgage(634)(166)
Net increase/(decrease) in short-term loans1,992(5,249)
Employee stock purchase plan1,8471,645
Exercise of stock options4,7075,841
Excess tax benefit on exercise of stock options333628
Share repurchase(49,998)(50,000)
Net cash used in financing activities(41,753)(47,301)
Effect of exchange rates on cash and cash equivalents(359)328
Net decrease in Cash and Cash Equivalents(13,286)(26,513)
Cash and Cash Equivalents at Beginning of Year196,707141,562
Cash and Cash Equivalents at End of Period183,421[1]115,049
Non-cash Investing and Financing Activities:  
Transfers from inventory to fixed assets for placements of Haemonetics equipment6,2923,710
Supplemental Disclosures of Cash Flow Information:  
Interest paid220251
Income taxes paid$ 2,288$ 6,941
[1](unaudited)